BCR/ABL EXPRESSION IN CHRONIC MYELOPROLIFERATIVE DISORDERS

被引：0
|
作者：
Kesaeva, L. [1 ]
Misyurin, A. [1 ]
Misyurina, E. [1 ]
Krutov, A. [1 ]
Soldatova, I. [1 ]
Kaysina, K. [1 ]
机构：
[1] GeneTechnol LLC, Moscow, Russia
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P826
引用
收藏
页码：346 / 346
页数：1
相关论文
共 50 条
  • [31] Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms
    Belliere, Julie
    Colombat, Magali
    Kounde, Clement
    Recher, Christian
    Ribes, David
    Huart, Antoine
    Chauveau, Dominique
    Demas, Veronique
    Luquet, Isabelle
    Beyne-Rauzy, Odile
    Tavitian, Suzanne
    Faguer, Stanislas
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (03): : 737 - 745
  • [32] CONTRIBUTION OF BONE MARROW DERIVED CELL ANGIOGENESIS IN BCR/ABL NEGATIVE CHRONIC MYELOPROLIFERATIVE DISEASE
    Gritti, G.
    Gianelli, U.
    Lonati, S.
    Silvestris, I.
    Vener, C.
    Boiocchi, L.
    Freyrie, A.
    Cortelezzi, A.
    Lambertenghi, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 355 - 355
  • [33] Risk-adapted treatment of chronic BCR-ABL1 negative myeloproliferative neoplasms
    Heidel, Florian H.
    Doehner, Konstanze
    ONKOLOGE, 2019, 25 (11): : 985 - 993
  • [34] Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease
    Agarwal, Anupriya
    Bumm, Thomas G. P.
    Corbin, Arnie S.
    O'Hare, Thomas
    Loriaux, Marc
    VanDyke, Jonathan
    Willis, Stephanie G.
    Deininger, Jutta
    Nakayama, Keiichi I.
    Druker, Brian J.
    Deininger, Michael W.
    BLOOD, 2008, 112 (05) : 1960 - 1970
  • [35] Identification of a dual JAK-2/BCR-ABL kinase inhibitor for treatment of myeloproliferative disorders
    Jatiani, Shashidhar
    Cosenza, Stephen
    Pallela, Venkat
    Ha, Ji Hee
    Baker, Stacey
    Reddy, M. V.
    Reddy, E.
    CANCER RESEARCH, 2009, 69
  • [36] Polemic Diagnostic Forum, prognosis and treatment of the Myeloproliferative BCR BCR / ABL negative syndromes
    Briere, Jean
    HEMATOLOGIE, 2009, 15 : 3 - 3
  • [37] Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders
    Kim, Yeo-Kyeoung
    Shin, Myung-Geun
    Kim, Hye-Ran
    Yang, Deok-Hwan
    Cho, Sang-Hee
    Lee, Je-Jung
    Chung, Ik-Joo
    Ryang, Dong-Wook
    Kim, Hyeoung-Joon
    LEUKEMIA RESEARCH, 2008, 32 (06) : 993 - 995
  • [38] IMPLICATIONS OF JAK2 MUTATION (V617F) ON THE EVOLUTION AND PROGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS BCR-ABL NEGATIVE
    Balea, M.
    Georgescu, D.
    Nicorescu, I.
    Ilea, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 606 - 606
  • [39] Novel translocations that disrupt the platelet-derived growth factor receptor β (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders
    Baxter, EJ
    Kulkarni, S
    Vizmanos, JL
    Jaju, R
    Martinelli, G
    Testoni, N
    Hughes, G
    Salamanchuk, Z
    Calasanz, MJ
    Lahortiga, I
    Pocock, CF
    Dang, R
    Fidler, C
    Wainscoat, JS
    Boultwood, J
    Cross, NCP
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) : 251 - 256
  • [40] Genetic analysis of BCR-ABL negative chronic myeloproliferative diseases at initial diagnosis and their clinical effects
    Uysal, Ayse
    Altiner, Sule
    Celik, Said
    Uysal, Serhat
    Cebi, Alper Han
    CUKUROVA MEDICAL JOURNAL, 2020, 45 (03): : 933 - 939
12345